Article

  • The EMBO Journal (1999) 18, 1303 - 1308
  • doi:10.1093/emboj/18.5.1303

Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes

Tomoya Miyakawa1, Akito Maeda2, Toshiko Yamazawa1, Kenzo Hirose1, Tomohiro Kurosaki2 and Masamitsu Iino1

  1. Department of Pharmacology, Faculty of Medicine, The University of Tokyo, CREST, Japan Science and Technology Corporation, Bunkyo-ku, Tokyo, 113, Japan
  2. Akito Maeda, Tomohiro Kurosaki, Department of Molecular Genetics, Institute for Liver Research, Kansai Medical University, Moriguchi 570, Japan

Correspondence to:

Masamitsu Iino, E-mail: iino@m.u-tokyo.ac.jp

Received 2 July 1998; Accepted 12 January 1999; Revised 12 December 1998


Inositol 1,4,5-trisphosphate (IP3) plays a key role in Ca2+ signalling, which exhibits a variety of spatio-temporal patterns that control important cell functions. Multiple subtypes of IP3 receptors (IP3R-1, -2 and -3) are expressed in a tissue- and development-specific manner and form heterotetrameric channels through which stored Ca2+ is released, but the physiological significance of the differential expression of IP3R subtypes is not known. We have studied the Ca2+-signalling mechanism in genetically engineered B cells that express either a single or a combination of IP3R subtypes, and show that Ca2+-signalling patterns depend on the IP3R subtypes, which differ significantly in their response to agonists, i.e. IP3, Ca2+ and ATP. IP3R-2 is the most sensitive to IP3 and is required for the long lasting, regular Ca2+ oscillations that occur upon activation of B-cell receptors. IP3R-1 is highly sensitive to ATP and mediates less regular Ca2+ oscillations. IP3R-3 is the least sensitive to IP3 and Ca2+, and tends to generate monophasic Ca2+ transients. Furthermore, we show for the first time functional interactions between coexpressed subtypes. Our results demonstrate that differential expression of IP3R subtypes helps to encode IP3-mediated Ca2+ signalling.

  • Keywords:

    • calcium,
    • calcium imaging,
    • gene targeting,
    • inositol 1,4,5-trisphosphate,
    • IP3 receptor